Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/49340
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSternberg, CN-
dc.contributor.authorSquifflet, P-
dc.contributor.authorSaad, ED-
dc.contributor.authorBurdett, S-
dc.contributor.authorFisher, D-
dc.contributor.authorKurt, M-
dc.contributor.authorTeitsson, S-
dc.contributor.authorMay, JR-
dc.contributor.authorPatel, MY-
dc.contributor.authorStoeckle, M-
dc.contributor.authorTorti, F-
dc.contributor.authorCote, R-
dc.contributor.authorRuggeri, EM-
dc.contributor.authorZhegalik, A-
dc.contributor.authorTierney, JF-
dc.contributor.authorCollette, L-
dc.contributor.authorBURZYKOWSKI, Tomasz-
dc.contributor.authorBUYSE, Marc-
dc.date.accessioned2026-06-17T13:17:41Z-
dc.date.available2026-06-17T13:17:41Z-
dc.date.issued2025-
dc.date.submitted2026-06-17T13:12:29Z-
dc.identifier.citationUrologic oncology, 43 (11) , p. 661e9 -661e17-
dc.identifier.urihttp://hdl.handle.net/1942/49340-
dc.description.abstractSurrogates for overall survival (OS) can expedite the development of adjuvant treatments for bladder cancer. We evaluated whether disease-free survival (DFS) or distant metastasis-free survival (DMFS) are valid surrogates for OS in patients with muscle-invasive disease treated with cisplatin-based chemotherapy after radical cystectomy.-
dc.description.sponsorshipAcknowledgments The authors thank the patients and families who made this study possible, the clinical study teams who participated, Bristol Myers Squibb (Princeton, NJ) and Ono Pharmaceutical Company Ltd. (Osaka, Japan). One of the authors of this article, Dr. Frank M. Torti, passed away before submitting this work. The rest of the authors would like to express their gratitude and admiration to him and also expect that this article serves as a tribute to his memory.-
dc.language.isoen-
dc.publisherELSEVIER SCIENCE INC-
dc.rights2025 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)-
dc.subject.otherBladder neoplasms-
dc.subject.otherPlatinum compounds-
dc.subject.otherAdjuvant therapy-
dc.subject.otherSurrogate endpoints-
dc.subject.otherOverall survival-
dc.subject.otherDisease-free survival-
dc.titleEvaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy-
dc.typeJournal Contribution-
dc.identifier.epage661e17-
dc.identifier.issue11-
dc.identifier.spage661e9-
dc.identifier.volume43-
local.format.pages9-
local.bibliographicCitation.jcatA1-
local.publisher.placeSTE 800, 230 PARK AVE, NEW YORK, NY 10169-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1016/j.urolonc.2025.07.013-
dc.identifier.pmid40846531-
dc.identifier.isi001588656100006-
local.provider.typeWeb of Science-
local.uhasselt.internationalyes-
item.fulltextWith Fulltext-
item.fullcitationSternberg, CN; Squifflet, P; Saad, ED; Burdett, S; Fisher, D; Kurt, M; Teitsson, S; May, JR; Patel, MY; Stoeckle, M; Torti, F; Cote, R; Ruggeri, EM; Zhegalik, A; Tierney, JF; Collette, L; BURZYKOWSKI, Tomasz & BUYSE, Marc (2025) Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy. In: Urologic oncology, 43 (11) , p. 661e9 -661e17.-
item.contributorSternberg, CN-
item.contributorSquifflet, P-
item.contributorSaad, ED-
item.contributorBurdett, S-
item.contributorFisher, D-
item.contributorKurt, M-
item.contributorTeitsson, S-
item.contributorMay, JR-
item.contributorPatel, MY-
item.contributorStoeckle, M-
item.contributorTorti, F-
item.contributorCote, R-
item.contributorRuggeri, EM-
item.contributorZhegalik, A-
item.contributorTierney, JF-
item.contributorCollette, L-
item.contributorBURZYKOWSKI, Tomasz-
item.contributorBUYSE, Marc-
item.accessRightsOpen Access-
crisitem.journal.issn1078-1439-
crisitem.journal.eissn1873-2496-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
main.pdfPublished version642.39 kBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.